HI SB 1280
died on adjournmentRELATING TO CONSUMER PROTECTION.
Hawaii · 2026 Regular Session · upper
Description
Prohibits covered entities in the State from entering into contracts with drug manufacturers that limit the covered entities' use of contract pharmacies. Voids contract provisions for certain drugs if the provisions are based on the maximum allowable cost payment model. Authorizes the attorney general to bring a civil action for violations.
- Introduced
- 2025-01-23
- Status date
- —
- Latest action
- 2025-12-08 — Carried over to 2026 Regular Session.
- Bill type
- bill
- Last updated
- —
Subjects
Sponsors
- AQUINOprimary
- CHANGprimary
- FEVELLAprimary
- MCKELVEYprimary
- San Buenaventuracosponsor
Committees
Not provided by source.
Action timeline
2025-12-08
Carried over to 2026 Regular Session.
carried-over
2025-01-27
Referred to CPN/HHS, JDC.
referral-committee
2025-01-23
Introduced and passed First Reading.
introduction,reading-1
2025-01-21
Pending Introduction.
Versions
- SB1280Compare
Documents
- application/pdf
- text/html(no extracted text yet)
Votes
Not provided by source.
Related bills
- Companion bill: HB 562
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:20:09.051962Z
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=HI&identifier=SB 1280. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
- Some documents have no extracted text yet, so version comparison may be limited.
See the methodology page for data sources and limitations.